Gardner Cameron Dales - Jul 14, 2021 Form 4 Insider Report for Enovix Corp (ENVX)

Role
Chief Commercial Officer
Signature
/s/ Edward J. Hejlek, Attorney-in-Fact for Gardner Cameron Dales
Stock symbol
ENVX
Transactions as of
Jul 14, 2021
Transactions value $
$0
Form type
4
Date filed
7/16/2021, 08:57 PM
Next filing
Mar 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENVX Common Stock Award +989K 989K Jul 14, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENVX Stock Option (Right to Buy) Award +13.8K 13.8K Jul 14, 2021 Common Stock 13.8K $0.05 Direct F1, F2, F3
transaction ENVX Stock Option (Right to Buy) Award +110K 110K Jul 14, 2021 Common Stock 110K $9.26 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation.
F2 The shares subject to the option vest in 48 equal monthly installments beginning on the vesting commencement date, September 1, 2017, subject to Reporting Person's continuous service through each such vesting date.
F3 Received in exchange for a stock option to purchase 75,000 shares of Legacy Enovix Common Stock.
F4 The shares subject to the option are immediately exercisable. 1/120th of the shares subject to the option vest monthly over 4 years beginning on the vesting commencement date, April 18, 2021, and 1/20th of the shares subject to the option vest monthly thereafter over the next year, subject to Reporting Person's continuous service through each such vesting date.
F5 Received in exchange for a stock option to purchase 596,800 shares of Legacy Enovix Common Stock.